Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
30
CAL Quote, Financials, Valuation and Earnings
Last price:
$13.72
Seasonality move
:
-1.15%
Day range:
$12.93 - $13.62
52-week range:
$12.09 - $44.51
Dividend yield:
2.09%
P/E ratio:
5.58x
P/S ratio:
0.17x
P/B ratio:
0.75x
Volume:
651.2K
Avg. volume:
942.3K
1-year change:
-61.04%
Market cap:
$452.5M
Revenue:
$2.7B
EPS (TTM):
$2.40
Analysts' Opinion
-
Consensus RatingCaleres has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.50, Caleres has an estimated upside of 45.63% from its current price of $13.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $13.39.
Fair Value
-
According to the consensus of 2 analysts, Caleres has 45.63% upside to fair value with a price target of $19.50 per share.
CAL vs. S&P 500
-
Over the past 5 trading days, Caleres has underperformed the S&P 500 by -5.16% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Caleres does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Caleres revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Caleres reported revenues of $614.2M.
Earnings Growth
-
Caleres earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Caleres reported earnings per share of $0.21.
Enterprise value:
685.6M
EV / Invested capital:
0.79x
Price / LTM sales:
0.17x
EV / EBIT:
5.83x
EV / Revenue:
0.26x
PEG ratio (5yr expected):
1.37x
EV / Free cash flow:
2,109.61x
Price / Operating cash flow:
1,367.87x
Enterprise value / EBITDA:
3.91x
Gross Profit (TTM):
$1.2B
Return On Assets:
4.32%
Net Income Margin (TTM):
3.11%
Return On Equity:
13.8%
Return On Invested Capital:
10.23%
Operating Margin:
1.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $2.9B | $2.8B | $2.7B | $659.2M | $614.2M | |
| Gross Profit | $1.3B | $1.3B | $1.2B | $309.1M | $278.7M | |
| Operating Income | $200.6M | $193.7M | $126.5M | $42.8M | $12.2M | |
| EBITDA | $258.1M | $247.4M | $175.4M | $57.2M | $27.1M | |
| Diluted EPS | $4.56 | $4.72 | $2.40 | $0.88 | $0.21 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $757.1M | $933.6M | $820.9M | $805.3M | $846.4M | |
| Total Assets | $1.8B | $1.9B | $1.8B | $1.9B | $1.9B | |
| Current Liabilities | $865.9M | $1.1B | $879.3M | $764.4M | $770.3M | |
| Total Liabilities | $1.6B | $1.6B | $1.4B | $1.3B | $1.3B | |
| Total Equity | $206.7M | $358M | $451.9M | $577M | $612.9M | |
| Total Debt | $399M | $305M | $291.5M | $191M | $258.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $143.7M | $198.7M | $62.8M | $36.1M | -$5.7M | |
| Cash From Investing | -$58.9M | -$53.4M | -$62.5M | -$10.3M | -$21.1M | |
| Cash From Financing | -$82.2M | -$150.9M | $2.1M | -$16.4M | $30.3M | |
| Free Cash Flow | $84.8M | $145.3M | $325K | $25.7M | -$26.8M | |
CAL
Sector
Market Cap
$452.5M
$426.2M
Price % of 52-Week High
30.08%
73.88%
Dividend Yield
2.09%
0%
Shareholder Yield
9.48%
4%
1-Year Price Total Return
-61.04%
-11.07%
Beta (5-Year)
1.032
0.767
Dividend yield:
2.09%
Annualized payout:
$0.28
Payout ratio:
11.55%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$13.93
200-day SMA
Sell
Level
$20.67
Bollinger Bands (100)
Sell
Level
13.69 - 16.89
Chaikin Money Flow
Buy
Level
43.3M
20-day SMA
Buy
Level
$13.31
Relative Strength Index (RSI14)
Sell
Level
46.73
ADX Line
Sell
Level
14.04
Williams %R
Neutral
Level
-56.5217
50-day SMA
Sell
Level
$14.40
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
28.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3603)
Sell
CA Score
(Annual)
Level (-0.3796)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.4011)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company’s business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
Stock Forecast FAQ
In the current month, CAL has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CAL average analyst price target in the past 3 months is $19.50.
-
Where Will Caleres Stock Be In 1 Year?
According to analysts, the consensus estimate is that Caleres share price will rise to $19.50 per share over the next 12 months.
-
What Do Analysts Say About Caleres?
Analysts are divided on their view about Caleres share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Caleres is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is Caleres's Price Target?
The price target for Caleres over the next 1-year time period is forecast to be $19.50 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CAL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Caleres is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CAL?
You can purchase shares of Caleres via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Caleres shares.
-
What Is The Caleres Share Price Today?
Caleres was last trading at $13.72 per share. This represents the most recent stock quote for Caleres. Yesterday, Caleres closed at $13.39 per share.
-
How To Buy Caleres Stock Online?
In order to purchase Caleres stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
